The AAPS Nanotechnology, Lipid-Based Drug Delivery and Modified Release Communities are inviting you to this webinar featuring Dr. Francis Szoka, Professor Emeritus at UCSF and a true pioneer in liposomal drug delivery.
Dr. Szoka co-founded Sequus, the company that developed Doxil™ , the first FDA-approved liposomal chemotherapy and has mentored generations of researchers in the Bay Area and beyond.
📅 Thursday, May 15 | 12:30–2:00 PM ET
🎤 Webinar: Liposomes-From the Laboratory to the Clinic
🧪 Moderated by me in my role as Chair of the AAPS Nanotechnology Community
🔗 Register here: https://science360.aaps.org/science360/2025/webinars-2025/4151920/faculty.presenters.liposomes-.from.the.laboratory.to.the.clinic.html?f=menu%3D24%2Ac_id%3D4151920%2Afeatured%3D19452%2Ashow_banner_in_top_panel%3D1
If you work in biologics, drug delivery, or formulation science, this is one you won't want to miss. I'd love to see you there and welcome your questions during the session!
------------------------------
Mitra Mosharraf, PhD
Chair, AAPS Nanotechnology
HTD Biosystems, CSO
[email protected]Livermore, CA
Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------